Private Advisor Group’s Kyntra Bio KYNB Stock Holding History

Private Advisor Group’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5	Closed	-$5K	–	2209
2020 Q2	$5K	Buy	+5	New	+$4.64K	﹤0.01%	3229

Other funds holding KYNB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Private Advisor Group's KYNB Position: Q3 2020 in Review

Private Advisor Group sold out of Kyntra Bio (KYNB) in Q3 2020, closing a stake of 5 shares — an estimated $5K sold.

Private Advisor Group first reported a position in KYNB in Q2 2020 and held it in 1 quarter. The position peaked at $5K in Q2 2020. 208 funds tracked by Wall St. Rank hold KYNB as of Q3 2020.

Private Advisor Group reported no remaining Kyntra Bio position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 5 Kyntra Bio shares in Q3 2020, an estimated $5K.
Private Advisor Group first reported a position in Kyntra Bio in Q2 2020 and held it in 1 quarter.
Private Advisor Group's Kyntra Bio position peaked at $5K in Q2 2020.
208 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.